Quantitative follow-up of patients with multiple sclerosis using MRI: Technical aspects

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 4, 1999, Pages 519-530

  Kikinis, Ron ^a   Guttmann, Charles R G ^a   Metcalf, David ^a   Wells III, William M ^a   Ettinger, Gil J ^a   Weiner, Howard L ^b   Jolesz, Ferenc A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain; Image processing; Magnetic resonance (MR); Multiple; Sclerosis; Surface rendition; Volume; Volume measurement; White matter

Indexed keywords

ADULT; ALGORITHM; ARTICLE; AUTOMATION; CASE REPORT; DATA ANALYSIS; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; STATISTICAL ANALYSIS;

ADULT; ALGORITHMS; BRAIN; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; SOFTWARE DESIGN; TIME FACTORS;

EID: 0032956264     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199904)9:4<519::AID-JMRI3>3.0.CO;2-M     Document Type: Article

References (68)

1. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol 1996;39:6-16.
2. Grossman RI, Braffman BH, Brorson JR, Goldberg HI, Silberberg DH, Gonzalez-Scarano F. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 1988;169:117-122.
3. Kappos L, Stadt D, Ratzka M, et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 1988;30:299-302.
4. Khoury SJ, Guttmann CRG, Orav EJ, et al. Longitudinal MRI imaging in multiple sclerosis: correlation between disability and lesion burden. Neurology 1994;44:2120-2124.
5. The IFNB Study Group, University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized, controlled trial. Neurology 1995;45:1277-1285.
6. Andersen O, Lycke J, Tollesson PO, et al. Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis. Neurology 1996;47:895-900.
7. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions ("black holes") on T1 spinecho MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476.
8. Zijdenbos AP, Dawant BM. Brain segmentation and white matter lesion detection in MR images. Crit Rev Biomed Eng 1994;22:401-465.
9. Filippi M, Horsfield MA, Tofts PS, Barkoff F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 1995;118:1601-1612.
10. Zijdenbos AP, Dawant BM, Margolin RA, Palmer AC. Morphometric analysis of white matter lesions in MR images: method and validation. IEEE Trans Med Imaging 1994;13:716-724.
11. Vannier MW. Pilgram TK. Speidel CM, Neumann LR, Rickman DL, Schertz LD. Validation of magnetic resonance imaging (MRI) multispectral tissue classification. Comput Med Imaging Graphics 1991;15:217-223.
12. Wicks DAG, Tofts PS, Miller DH, et al. Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study. Neuroradiology 1992;34:475-479.
13. Paty DW, Li DK, UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trail [see comments]. Neurology 1993;43:662-667. Comment in: Neurology 1993; 43:641-643.
14. Paty DW, Li DK, UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trail [see comments]. Neurology 1993;43:662-667. Comment in: Neurology 1993; 43:641-643.
15. Filippi M, Horsfield MA, Bressi S. et al. Intra- and inter-observer variability of brain MRI lesion volume measurements in multiple sclerosis: a comparison of techniques. Brain 1995;188:1593-1600.
16. Mitchell JR, Karlik SJ, Lee DH, Eliasziw M, Rice GP, Fenster A. The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Med Phys 1996;23:85-97.
17. Wells WM III, Crimson WEL, Kikinis R, Jolesz FA. Adaptive segmentation of MRI data. IEEE Trans Med Imaging 1996;15:429-442.
18. Vannier MW, Butterfield RL, Jordan D, et al. Multispectral analysis of magnetic resonance images. Radiology 1985;154:221-224.
19. O'Donnell M, Gore JC, Adams WJ. Toward an automated analysis system for nuclear magnetic resonance imaging. II. Initial segmentation algorithm. Med Phys 1986;13:293-297.
20. Levin DN, Hu X, Tan KK, Galhotra S. Surface of the brain: three-dimensional MR images created with volume rendering. Radiology 1989;171:227-280.
21. Lim KO, Pfefferbaum A. Segmentation of MR brain images into cerebrospinal fluid spaces, white and gray matter. J Comput Assist Tomogr 1989;13:558-593.
22. Filipek PA, Kennedy DN, Caviness VS. et al. Magnetic resonance imaging-based brain morphometry: development and application to normal subjects. Ann Neurol 1989;25:61-67.
23. Cline HE, Lorensen WE, Kikinis R, Jolesz F. Three-dimensional segmentation of MR images of the head using probability and connectivity. J Comput Assist Tomogr 1990;14:1037-1045.
24. Prasad Raya S. Low-level segmentation of 3-D magnetic resonance brain images - a rule-based system. IEEE Trans Med Imaging 1990;9:327-337.
25. Kohn MI, Tanna NK, Herman GT, et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging. I. Methods, reliability and validation. Radiology 1991;178:115-122.
26. Jackson EF, Narayana PA, Falconer JC. Reproducibility of nonparametric feature map segmentation for determination of normal human intracranial volumes with MR imaging data. J Magn Reson Imaging 1994;4:692-700.
27. Jackson EF, Narayana PA, Wolinsky JS, Doyle TJ. Accuracy and reproducibility in volumetric analysis of multiple sclerosis lesions. J Comput Assist Tomogr 1993;17:200-205.
28. Kikinis R, Shenton ME, Gerig G, et al. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging 1992;2:619-629.
29. Metcalf D, Kikinis R, Guttmann C, Vaina L, Jolesz F. 4D connected component labelling applied to quantitative analysis of MS lesion temporal development. In: Proceedings of the 14th Annual International Conference of the IEEE-EMBS, Paris, 1992. Vol. 3. p 945-946.
30. Kikinis R, Metcalf D, Guttmann C, Gleason PL, Jolesz FA. Quantitative analysis of the temporal development of MS lesion. In: Proceedings of the 31st Annual Meeting of the American Society of Neuroradiology. Vancouver, BC, May, 1993. p 255-256 (Poster 137).
31. Kikinis R, Guttmann CRG, Metcalf D, Anderson MC, Jolesz FA. Volumetric quantitation of the development of focal lesions in multiple sclerosis. Neuroradiology 1993;35:108 (abstract).
32. Gerig G, Kübler O, Kikinis R, Jolesz FA. Nonlinear anisotropic filtering of MRI data. IEEE Trans Med Imaging 1992;11:221-232.
33. Ettinger GJ, Crimson WEL, Lozano-Perez T, Wells WM, White SJ, Kikinis R. Automatic registration for multiple sclerosis change detection. Presented at the IEEE Workshop on Biomedical Image Analysis, Seattle WA, June 1994.
34. Guttmann CRG, Kikinis R, Metcalf D, Jolesz FA. Automated volumetric and morphologic analysis of the evolution of focal multiple sclerosis lesions. J Magn Reson Imaging 1994;4:88-89 (abstract 447).
35. Tanna NK, Kohn MI, Horwich DN, et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for Atrophy. Part II. Aging and Alzheimer dementia. Radiology 1991;178:123-130.
36. Rusinek H, de Leon MJ, George AE, et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Neuroradiology 1991;178:109-114.
37. Shenton ME, Kikinis R, Jolesz FA, et al. Left temporal lobe abnormalities in schizophrenia and thought disorder. N Engl J Med 1992;327:604-612.
38. Matsumae M, Kikinis R, Mórocz I, et al. Intracranial compartment volumes in patients with enlarged ventricles assessed by magnetic resonance-based image processing. J Neurosurg 1996;84:972-981.
39. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines [see comments]. J Neurol Neurosurg Psychiatry 1991;54:683-688. Comment in: J Neurol Neurosurg Psychiatry 1992;55:978.
40. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines [see comments]. J Neurol Neurosurg Psychiatry 1991;54:683-688. Comment in: J Neurol Neurosurg Psychiatry 1992;55:978.
41. Wells WM III, Kikinis R, Crimson WEL, Jolesz FA. Statistical intensity correction and segmentation of MRI data. Lecture Notes Comput Sci 1995;905:59.
42. Guttmann CRG, Kikinis R, Hsu L, Ahn SS, Jolesz FA. Automated quantitation of lesion distribution within anatomic regions in multiple sclerosis. Hum Brain Mapping 1995;Suppl 1:134 (abstract).
43. Guttmann CRG, Weiner HL, Kikinis R, et al. A prospective study of multiple sclerosis: correlation between MRI, clinical and immunological findings. Proc Soc Magn Reson 1995;2:1292.
44. Guttmann CRG, Kikinis R, Anderson MC, Jakab M, Weiner HL, Jolesz FA. Quantitative follow-up of patients with multiple sclerosis using MRI: reproducibility. J Magn Reson Imaging 1998;9:509-518.
45. Serra J. Image analysis in mathematical morphology. Orlando, FL: Academic Press, 1992.
46. Crimson WEL, Ettinger GJ, White SJ, Lozano-Perez T, Wells WM, Kikinis R. An automatic registration method for frameless stereotaxy, image guided surgery, and enhanced reality visualization. IEEE Trans Med Imaging 1996;15:129-140.
47. Stone LA, Albert PS, Smith ME, et al. Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology 1995;45:1808-1814.
48. Zijdenbos A, Evans A, Riahi F, Sled J, Chui H-C, Kollokian V. Automatic quantification of multiple sclerosis lesion volume using stereotactic space. In: Proceedings of the Fourth International Conference on Visualization in Biomedical Computing (VBC), Hamburg, Germany, 1996.
49. Gonzalez C, Vinitski S, Mohammed F, et al. MS lesion characterization using tissue segmentation based on 3D feature map. In: Proceedings of the Workshop held at Montreal Neurological Institute, Montreal, Quebec, Canada; November 6-7, 1995. p 26.
50. Miki Y, Grossman RI, Udupa JK. et al. Computer-assisted quantitation of enhancing lesions in multiple sclerosis: correlation with clinical classification. AJNR 1997;18:705-710.
51. Lukfin RB, Sharpless T, Flannigan B. Hanafee W. Dynamic range compression in surface coil MRI. AJR 1986;147:379-382.
52. Axel L, Costantini J, Listerud J. Intensity correction in surface coil MR imaging. AJR 1987;148:418-420.
53. Wicks DA, Barker GJ, Tofts PS. Correction of intensity non-uniformity in MR images of any orientation. Magn Reson Imaging 1993;11:183-196.
54. Johnston B, Atkins MS, Macklewich B, Anderson M. Segmentation of multiple sclerosis lesions in intensity corrected multispectral MRI. IEEE Trans Med Imaging 1996;15:278-293.
55. Kamber M, Shinghal R, Collins DL, Francis GS, Evans AC. Model-based 3-D segmentation of multiple sclerosis lesions in magnetic resonance brain images. IEEE Trans Med Imaging 1995;14:442-453.
56. Neiw HM, Chen CT, Lin WC, Pelizzari CA. Automated three-dimensional registration of medical images. Medical imaging V: Image capture, formatting, and display. SPIE 1991;1445:259-264.
57. Pelizzari CA, Chen GTY, Spelbring DR, Weichselbaum RR, Chen CT. Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr 1989;13:20-26.
58. Pelizzari CA, Tan KK, Levin DN, Chen GTY, Balter J. Interactive 3D patient-image registration. Information processing in medical imaging. In: 12th International Conference, IPMI 1991 Proceedings. p 132-141.
59. Champleboux G, Lavalee S, Szeliski R, Brunie L. From accurate range imaging sensor calibration to accurate model-based 3D object localization. Presented at the IEEE Conference on Computer Vision and Pattern Recognition, 1992. p 83-89.
60. Szeliski R, Lavalee S. Matching 3D anatomical surfaces with non-rigid deformations using octree-splines. In: SPIE Geometric Methods in Computer Vision II, 1993. p 2031.
61. Ayache N, Boissonnat JD, Cohen L. et al. Steps toward the automatic interpretation of 3-D images. In: Fuchs H, Hohne K, Pizer S, editors. 3D imaging in medicine. NATO ASI Series. New York: Springer-Verlag; 1990. p 107-120.
62. Gueziec A, Ayache N. Smoothing and matching of 3-D space curves. In: Proceedings of the Second European Conference on Computer Vision, May 1992. p 620-629.
63. Gueziec A. Large deformable splines, crest lines and matching. INRIA TR 1782, October 1992.
64. Kovacic S, Gee JC, Ching WSL, Reivich M, Bajcsy. Three-dimensional registration of PET and CT images. In: Images of the twenty-first century - proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1989. p 548-549.
65. Hohol MJ, Guttmann CRG, Orav J, et al. Serial neuropsychological assessment and MRI analysis in multiple sclerosis. Arch Neurol 1997;54:1018-1025.
66. Hohol M, Guttmann C, Olek M, et al. Roquinimex (Linomide) treatment in secondary progressive and relapsing remitting multiple sclerosis: results from 48 week randomized, double-blind, placebo-controlled pilot studies. Neurology 1997;48:A174.
67. Guttmann CRG, Ahn SS, Hsu L, Kikinis R, Jolesz, FA. The evolution of multiple sclerosis lesions on serial MRI. AJNR 1995;16:1481-1491.
68. Warfield S, Dengler J, Zaers J, et al. Automatic identification of gray matter structures from MRI to improve the segmentation of white matter lesions. J Image Guided Surg 1996;1:326-338.